Suzhou Basecare Medical (HKSE:02170) PB Ratio : 0.35 (As of Jun. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-16), Suzhou Basecare Medical's share price is HK$1.96. Suzhou Basecare Medical's Book Value per Share for the quarter that ended in Dec. 2023 was HK$5.60. Hence, Suzhou Basecare Medical's PB Ratio of today is 0.35.

Good Sign:

Suzhou Basecare Medical Corp Ltd stock PB Ratio (=0.36) is close to 5-year low of 0.33

The historical rank and industry rank for Suzhou Basecare Medical's PB Ratio or its related term are showing as below:

HKSE:02170' s PB Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.57 Max: 26.54
Current: 0.35

During the past 6 years, Suzhou Basecare Medical's highest PB Ratio was 26.54. The lowest was 0.33. And the median was 0.57.

HKSE:02170's PB Ratio is ranked better than
96.42% of 782 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs HKSE:02170: 0.35

During the past 12 months, Suzhou Basecare Medical's average Book Value Per Share Growth Rate was -14.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 64.80% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Suzhou Basecare Medical was 64.80% per year. The lowest was 64.80% per year. And the median was 64.80% per year.

Back to Basics: PB Ratio

Suzhou Basecare Medical PB Ratio Historical Data

The historical data trend for Suzhou Basecare Medical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical PB Ratio Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

0.87

0.57

0.42

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial					0.87	0.67	0.57	0.47	0.42

Competitive Comparison of Suzhou Basecare Medical's PB Ratio

For the Medical Devices subindustry, Suzhou Basecare Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's PB Ratio falls into.

Suzhou Basecare Medical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Suzhou Basecare Medical's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.96	/	5.595
	=	0.35

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Suzhou Basecare Medical (HKSE:02170) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Suzhou Basecare Medical PB Ratio Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical (HKSE:02170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines